A review of the mechanisms underlying selected comorbidities in Alzheimer's disease.

Pharmacological Reports : PR
Karolina MaciejewskaPaweł Szymański

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central nervous system (CNS) leading to mental deterioration and devastation, and eventually a fatal outcome. AD affects mostly the elderly. AD is frequently accompanied by hypercholesterolemia, hypertension, atherosclerosis, and diabetes mellitus, and these are significant risk factors of AD. Other conditions triggered by the progression of AD include psychosis, sleep disorders, epilepsy, and depression. One important comorbidity is Down's syndrome, which directly contributes to the severity and rapid progression of AD. The development of new therapeutic strategies for AD includes the repurposing of drugs currently used for the treatment of comorbidities. A better understanding of the influence of comorbidities on the pathogenesis of AD, and the medications used in its treatment, might allow better control of disease progression, and more effective pharmacotherapy.

References

May 23, 2001·Progress in Neurobiology·N C Danbolt
Nov 30, 2002·Lancet·James ShepherdUNKNOWN PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk
Oct 27, 2005·International Journal of Geriatric Psychiatry·John KennedyRobert W Baker
Apr 14, 2007·Current Alzheimer Research·Rachel A WhitmerKristine Yaffe
Feb 11, 2009·Archives of Neurology·Jorge J Palop, Lennart Mucke
Mar 20, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rimante MinkevicieneHeikki Tanila
Nov 21, 2009·American Journal of Hypertension·Michiaki NagaiKazuomi Kario
Mar 2, 2010·The Journal of Nutrition, Health & Aging·S BomboisC Monaca
Mar 6, 2010·Journal of Intellectual Disability Research : JIDR·S LanfranchiR Vianello
Aug 11, 2010·Molecular and Cellular Neurosciences·Celine UllrichChristian Humpel
Feb 8, 2011·Lancet·Farshad FarzadfarUNKNOWN Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol)
Apr 29, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Orestes V ForlenzaWagner F Gattaz
May 17, 2011·The American Journal of Psychiatry·Cheryl L P VigenLon S Schneider
Jun 29, 2011·Journal of Alzheimer's Disease : JAD·Neil M DaviesRichard M Martin
Nov 11, 2011·CNS Neuroscience & Therapeutics·Daniel FriedmanNikolaos Scarmeas
Dec 29, 2011·Current Gerontology and Geriatrics Research·Marzia Perluigi, D Allan Butterfield
Jul 11, 2012·Journal of Alzheimer's Disease : JAD·Whitney WhartonCynthia M Carlsson
Aug 14, 2012·Journal of the Neurological Sciences·Raj N KalariaMasafumi Ihara
Oct 30, 2012·Stroke; a Journal of Cerebral Circulation·Carrington R WendellAlan B Zonderman
Nov 6, 2012·IUBMB Life·Roberta RicciarelliCinzia Domenicotti
Dec 4, 2012·Brain : a Journal of Neurology·Mark YarchoanSteven E Arnold
Jan 12, 2013·Dementia and Geriatric Cognitive Disorders·Brian S ApplebyJeffrey L Cummings
Jan 29, 2013·Expert Opinion on Pharmacotherapy·Peter Paul De DeynDebby Van Dam
May 7, 2013·Metabolic Brain Disease·Hui-Ting YangJiann-Liang Lin
Jul 20, 2013·Journal of Neuroinflammation·Donna M Wilcock, W Sue T Griffin
Aug 8, 2013·The International Journal of Neuroscience·M Obulesu, M Jhansilakshmi
Dec 3, 2013·Brain Imaging and Behavior·Leo UngarMichael D Greicius
Dec 18, 2013·Journal of Neurochemistry·W Gibson WoodGunter P Eckert
Feb 18, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Fernanda G De FeliceSergio T Ferreira
Feb 20, 2014·JAMA : the Journal of the American Medical Association·Anton P PorsteinssonUNKNOWN CitAD Research Group
Mar 19, 2014·Diabetes Research and Clinical Practice·L GuariguataJ E Shaw
Apr 16, 2014·Gerontology·Allal Boutajangout, Thomas Wisniewski
Jul 9, 2014·Frontiers in Aging Neuroscience·Nakisa MalakootiDavid I Finkelstein
Oct 23, 2014·The Journal of Biological Chemistry·Yanping ZhuDavid J Vocadlo
Dec 5, 2014·Neuropsychiatric Disease and Treatment·Jeremy Koppel, Blaine S Greenwald
Mar 7, 2015·Journal of the American College of Cardiology·Kimon StamatelopoulosKonstantinos Stellos
Jul 28, 2015·Bioorganic & Medicinal Chemistry Letters·Yao ChenHao-peng Sun
Aug 6, 2015·Nature Reviews. Neuroscience·Frances K WisemanAndré Strydom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.